126 related articles for article (PubMed ID: 4142421)
1. Influence of heparin and protamine on enlargement of the draining lymph node during induction of EAE.
Matous-Malbohan I; Arnason BG
Cell Immunol; 1974 Jun; 12(3):345-9. PubMed ID: 4142421
[No Abstract] [Full Text] [Related]
2. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
[No Abstract] [Full Text] [Related]
3. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
4. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
[No Abstract] [Full Text] [Related]
5. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
6. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
Brod SA; Scott M; Burns DK; Phillips JT
J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
[TBL] [Abstract][Full Text] [Related]
7. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
Coates A; Mackay IR; Crawford M
Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423
[No Abstract] [Full Text] [Related]
8. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
Killen JA; Swanborg RH
J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
10. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
11. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
Falk GA; Kies MW; Alvord EC
J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
[No Abstract] [Full Text] [Related]
12. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
[TBL] [Abstract][Full Text] [Related]
13. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
[No Abstract] [Full Text] [Related]
14. Characterization of the in vitro cytotoxic assay of immune lymphoid cells in experimental allergic encephalomyelitis (EAE).
Allbritton AR; Loan RW
Int Arch Allergy Appl Immunol; 1977; 53(4):376-84. PubMed ID: 67090
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
16. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
Whitacre CC; Paterson PY
J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
[TBL] [Abstract][Full Text] [Related]
17. Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features.
Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
J Neurol Sci; 1981 Oct; 52(1):133-45. PubMed ID: 6170738
[TBL] [Abstract][Full Text] [Related]
18. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
19. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
Weber F; Hempel K
Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
[TBL] [Abstract][Full Text] [Related]
20. Experimental allergic encephalomyelitis (EAE)-changes in structure and proliferation in rat lymph nodes after sensitization with guinea-pig and bovine basic myelin protein.
Matous-Malbohan I; Mares V; Lodin Z; Holub M
Experientia; 1977 Apr; 33(4):533-4. PubMed ID: 67964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
